CergenX has received FDA breakthrough device designation for its AI-powered neonatal EEG assessment tool, Wave. This designation allows for prioritized review and faster interaction with FDA experts during the premarket phase. The technology aims to enhance the evaluation of newborns' neurological states and detect potential brain injuries.
The Wave device utilizes AI to analyze EEG data in real-time, addressing a significant gap in neonatal care where many hospitals lack the resources for thorough assessments. With minimal training required for healthcare professionals, Wave promises to facilitate quicker interventions for at-risk newborns. CergenX's CEO highlighted this achievement as a transformative step for both the company and neonatal care globally.
• CergenX's Wave tool enhances neonatal brain injury detection using AI.
• FDA breakthrough designation accelerates CergenX's path to market.
CergenX's Wave is an AI-powered tool designed for real-time EEG analysis in newborns.
EEG is the gold standard for measuring brain activity, crucial for assessing newborns' neurological health.
The Wave device provides real-time analysis of EEG data, enabling immediate insights for healthcare professionals.
CergenX specializes in AI-driven medical devices, focusing on neonatal brain health assessments.
Ceribell develops AI software for EEG analysis, improving seizure detection and patient outcomes.
CNBC on MSN.com 12month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.